Topical retinoid (anti-acne)
Pregnancy: CONTRAINDICATED — all topical retinoids are contraindicated in pregnancy.
Adapalene 0.1% Topical
Brand names: Differin (0.1% cream/gel), Epiduo (adapalene 0.1% + benzoyl peroxide 2.5% — combination)
Adult dose
Dose: Apply a thin layer to the entire acne-prone area once daily at night
Route: Topical
Frequency: Once daily (evening — photosensitivity risk in daytime)
Max: Apply to affected area — avoid periorbital/mucosal areas
For comedonal and inflammatory acne vulgaris. Apply to entire acne-prone face (not just spots — comedonal prevention). Start with every other day if sensitive, increase to nightly after 2–4 weeks. Full effect at 3 months. Epiduo combines adapalene with benzoyl peroxide — highly effective.
Paediatric dose
Route: Topical
Frequency: Once daily (evening)
Max: Affected area only
Concentration: 0.1% gel or cream; 0.3% gel (Differin 0.3% — severe acne) Application/ml
Licensed ≥12 years. Apply to affected areas. Start with alternate nights if irritation occurs.
Dose adjustments
Renal
N/A — topical use.
Hepatic
N/A — topical use.
Clinical pearls
- Adapalene is better tolerated than tretinoin with equivalent efficacy — preferred topical retinoid in BAD/NICE acne guidelines
- Apply to whole face (field treatment) not just active spots — prevents new comedones from forming
- Retinoid dermatitis: expected peeling and redness in first month — advise patients in advance to prevent discontinuation
- Epiduo (adapalene + BPO) is NICE-recommended first-line combination for moderate acne — more effective than either alone
- Contraindicated in pregnancy — counsel all women of childbearing age
Contraindications
- Pregnancy (topical retinoids contraindicated)
- Breastfeeding (avoid applying to chest area)
- Eczematous or sunburned skin
- Hypersensitivity to adapalene or retinoids
Side effects
- Initial skin irritation, dryness, and peeling (retinoid dermatitis — expected in first 4–6 weeks)
- Erythema at application site
- Photosensitivity (use SPF daily)
- Initial acne flare (first 2–4 weeks — normal and temporary)
Interactions
- Other topical retinoids — do not combine
- Abrasive cleansers and astringents — additive skin irritation
- Benzoyl peroxide (in Epiduo) — effective combination; separate if used individually (apply in AM vs PM)
Monitoring
- Acne response at 3 months
- Skin tolerance (adjust frequency if severe irritation)
- Pregnancy status in women of childbearing potential
Reference: BNFc; BNF; BAD Acne Guidelines 2021; NICE CG184; Epiduo SPC. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Acne Severity Classification (IGA Scale) · Acne
- Revised Original International Autoimmune Hepatitis Score (IAIHG) · Autoimmune Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Rh(D) Immune Globulin Dosage for Maternal-Fetal Haemorrhage · Haematology in Pregnancy
- AREDS Classification of Age-related Macular Degeneration · Macular Degeneration
- Diabetic Macular Oedema (DMO) Classification · Diabetic Retinopathy
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD